ARCH Venture Partners X Overage, L.P.
Related Filers (24)
- ARCH Venture Partners X, LLC (13)
- ARCH Venture Fund X Overage, L.P. (13)
- ARCH Venture Fund X, L.P. (12)
- ARCH Venture Partners X, L.P. (12)
- CRANDELL KEITH (7)
- GILLIS STEVEN (7)
- Burow Kristina (6)
- NELSEN ROBERT (5)
- ARCH Venture Partners IX, LLC (3)
- Sana Biotechnology, Inc. (3)
- ARCH Venture Fund IX Overage, L.P. (3)
- ARCH Venture Partners IX Overage, L.P. (3)
- ARCH Venture Fund IX, L.P. (3)
- Neumora Therapeutics, Inc. (3)
- ARCH Venture Fund VII, L.P. (3)
- ARCH Venture Partners VII, L.P. (3)
- ARCH Venture Partners VII, LLC (3)
- ARCH Venture Fund VIII Overage, L.P. (3)
- ARCH Venture Partners VIII, LLC (3)
- ARCH Venture Partners IX, L.P. (2)
- Verve Therapeutics, Inc. (2)
- Erasca, Inc. (2)
- Prime Medicine, Inc. (2)
- Sienna Biopharmaceuticals, Inc. (1)
- Show More ...
Ownership (13)
4
Monday, 2/12/2024
Sana Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/12/2023
Neumora Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/20/2023
Neumora Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 9/14/2023
Neumora Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 10/26/2022
Prime Medicine, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/19/2022
Prime Medicine, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 7/20/2021
Erasca, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/15/2021
Erasca, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 6/23/2021
Verve Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/16/2021
Verve Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 2/10/2021
Sana Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/3/2021
Sana Biotechnology, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 2/26/2019
Sienna Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities